Statin therapy: Clinical trials, guidelines, and new directionsLAROSA, John C; PEDERSEN, Terje.The American journal of medicine. 2005, Vol 118, Num 12A, issn 0002-9343, 72 p.Conference Proceedings

Prevention of cardiovascular ischemic events: High-risk and secondary preventionGENEST, Jacques; PEDERSEN, Terje R.Circulation (New York, N.Y.). 2003, Vol 107, Num 15, pp 2059-2065, issn 0009-7322, 7 p.Article

Halting the progression of atherosclerosis with intensive lipid lowering : results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trialNISSEN, Steven E.The American journal of medicine. 2005, Vol 118, Num 12A, pp 22S-27S, issn 0002-9343Conference Paper

Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitusBETTERIDGE, John.The American journal of medicine. 2005, Vol 118, Num 12A, pp 10S-15S, issn 0002-9343Conference Paper

Statin therapy in the treatment of Alzheimer disease : what is the rationale?DEKOSKY, Steven T.The American journal of medicine. 2005, Vol 118, Num 12A, pp 48S-53S, issn 0002-9343Conference Paper

Statin use in a real-world clinical setting : aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trialKOREN, Michael J.The American journal of medicine. 2005, Vol 118, Num 12A, pp 16S-21S, issn 0002-9343Conference Paper

Barriers to effective implementation of guideline recommendationsERHARDT, Leif R.The American journal of medicine. 2005, Vol 118, Num 12A, pp 36S-41S, issn 0002-9343Conference Paper

A rationale for combination therapy in risk factor management : a mechanistic perspectiveMASON, R. Preston.The American journal of medicine. 2005, Vol 118, Num 12A, pp 54S-61S, issn 0002-9343Conference Paper

Potential vascular benefits of statinsKINLAY, Scott.The American journal of medicine. 2005, Vol 118, Num 12A, pp 62S-67S, issn 0002-9343Conference Paper

Proceedings of the 2nd international Merck symposium on HDL-C raising bridging the gap in cardiovascular risk reduction: a call to action, Barcelona, 14-15 October, 2005ILKOVA, Hasan; PEDERSEN, Terje R; SHEPHERD, James et al.European heart journal supplements. 2006, Vol 8F, issn 1520-765X, 82 p.Conference Proceedings

Lipid-lowering therapy and the patient with multiple risk factors : what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?SEVER, Peter S.The American journal of medicine. 2005, Vol 118, Num 12A, pp 3S-9S, issn 0002-9343Conference Paper

Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen : results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trialROULEAU, Jean.The American journal of medicine. 2005, Vol 118, Num 12A, pp 28S-35S, issn 0002-9343Conference Paper

What impact will current trial data have on future guideline recommendations?GRAHAM, Ian.The American journal of medicine. 2005, Vol 118, Num 12A, pp 42S-47S, issn 0002-9343Conference Paper

Pro and con : Low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid managementPEDERSEN, Terje R.The American journal of cardiology. 2001, Vol 87, Num 5A, pp 8B-12B, issn 0002-9149Conference Paper

Left Ventricular Systolic and Diastolic Function in Asymptomatic Patients With Moderate Aortic StenosisSTEINE, Kjetil; ROSSEBØ, Anne B; STUGAARD, Marie et al.The American journal of cardiology. 2008, Vol 102, Num 7, pp 897-901, issn 0002-9149, 5 p.Article

Overview of clinical trials on calcific aortic stenosisPEDERSEN, Terje R.European heart journal supplements. 2008, Vol 10, Num E, issn 1520-765X, E31-E40Article

Effect of simvastatin on kidney function loss in patients with coronary heart disease Findings from the Scandinavian Simvastatin Survival Study (4S)HUSKEY, Janna; LINDENFELD, Joann; COOK, Thomas et al.Atherosclerosis. 2009, Vol 205, Num 1, pp 202-206, issn 0021-9150, 5 p.Article

Cardiovascular risk and renal transplantation : Post hoc analyses of the assessment of lescol in renal transplantation (ALERT) studyJARDINE, Alan G; FELLSTRÖM, Bengt; OLSSON, Anders G et al.American journal of kidney diseases. 2005, Vol 46, Num 3, pp 529-536, issn 0272-6386, 8 p.Article

A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy Study to assess the efficacy of Atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: The Treat-to-Target (3T) StudyOLSSON, Anders G; ERIKSSON, Mats; JOHNSON, Owe et al.Clinical therapeutics. 2003, Vol 25, Num 1, pp 119-138, issn 0149-2918, 20 p.Article

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialBAIGENT, Colin; LANDRAY, Martin J; NEAL, Bruce et al.Lancet (British edition). 2011, Vol 377, Num 9784, pp 2181-2192, issn 0140-6736, 12 p.Article

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trialSEMB, Anne G; HOLME, Ingar; KVIEN, Tore K et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 2, pp 324-329, issn 1462-0324, 6 p.Article

A daily glass of red wine: Does it affect markers of inflammation?RETTERSTOL, Lars; BERGE, Knut Erik; BRAATEN, Øivind et al.Alcohol and alcoholism (Oxford). 2005, Vol 40, Num 2, pp 102-105, issn 0735-0414, 4 p.Article

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiencyCHONCHOL, Michel; COOK, Thomas; KJEKSHUS, John et al.American journal of kidney diseases. 2007, Vol 49, Num 3, pp 373-382, issn 0272-6386, 10 p.Article

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to Simvastatin therapy in 4SBALLANTYNE, Christie M; OLSSON, Anders G; COOK, Thomas J et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 25, pp 3046-3051, issn 0009-7322Article

Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin. CommentaryMARWICK, Thomas H; LINDGREN, Peter; GRAFF, Jennifer et al.European heart journal. 2007, Vol 28, Num 12, issn 0195-668X, 1407-1408, 1448-1453 [8 p.]Article